Deafness, aminoglycoside-induced
MONDO:0010799Also known as: aminoglycoside-induced hearing loss, mitochondrial isolated neurosensory hearing loss with susceptibility to aminoglycoside exposure, mitochondrial isolated sensorineural hearing loss with susceptibility to aminoglycoside exposure, mitochondrial non-syndromic neurosensory hearing loss with susceptibility to aminoglycoside exposure, mitochondrial non-syndromic sensorineural hearing loss with susceptibility to aminoglycoside exposure, deafness, aminoglycoside-induced, deafness, mitochondrial, modifier of, mitochondrial, deafness, streptomycin-induced
104 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New drug aims to tame hard-to-control seizures in rare mitochondrial disorders
Disease control TerminatedThis study tested a drug called vatiquinone in 68 people with mitochondrial disease and epilepsy that doesn't respond to standard treatments. Participants were randomly assigned to receive either vatiquinone or a placebo for 24 weeks to see if the drug could reduce the number of …
Phase: PHASE2, PHASE3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Cochlear implant study tests new sound processor for better hearing
Knowledge-focused TerminatedThis study tested how well adults with a NeuroZti cochlear implant could hear and how satisfied they were with two different sound processors: the current Neu2 and a newer Nuc8. Four participants attended a single 3-hour visit to compare speech understanding at normal and soft vo…
Phase: NA • Sponsor: Cochlear • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC